MedPath

Monitoring of MDRO Dynamics and Resistance Mechanisms in a University Hospital Network

Recruiting
Conditions
MDRO
Registration Number
NCT04937361
Lead Sponsor
University of Luebeck
Brief Summary

Survey on the prevalence of MDRO to monitor the import of MDRO from the community. Rectal swabs will be taken and cultivated. Survey on community-onset and nosocomial bloodstream infections will be documented and strains will be isolated. For each BSI a clinical data set will be obtained (e.g. patient age, gender, date of hospitalization, antibiotic therapy). Genetic analysis of MDRO from the prevalence and BSI study. In a subset of patients the microbiome-resistome interactome will be analysed in more detail. Furthermore, the impact of infection control measures due to the Covid-19 pandemic on nosocomial BSI will be investigated.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
12000
Inclusion Criteria
  • at least 18 years old
  • informed consent
  • inpatient
Exclusion Criteria
  • less than 18 years old
  • Not capable of giving informed consent
  • outpatient

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
monitoring of MDRO prevalenceat hospital admission

obtain a better understanding for the emergence of resistance within the microenvironment under selective pressure

integrate novel techniques for microbiome-resistome interaction analysisthrough study completion, after 4 years

obtain a better understanding for the emergence of resistance within the microenvironment under selective pressure

monitoring of blood stream infectionsduring hospitalization, up to 4 weeks

obtain a better understanding for the emergence of resistance within the microenvironment under selective pressure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Klinik für Infektiologie und Mikrobiologie

🇩🇪

Lübeck, Germany

© Copyright 2025. All Rights Reserved by MedPath